The role of inflammation in deep vein thrombosis (DVT) was es- To grasp the gravity of this translational work, it is important to understand the state of current treatments and outcomes in venous thromboembolism. Current projections for this disease estimate that 900,000 Americans will develop DVT every year with the affected population expected to double by 2050. 5 Moreover, the cost of post-thrombotic syndrome, a long-term complication of DVT, is approximately 3 billion dollars per year in the US. 6 Why is post thrombotic syndrome such a significant financial burden? Because our current treatments for DVT do not effectively prevent post thrombotic syndrome or recurrent episodes of DVT. In fact, to give some perspective, the standard treatment of anticoagulation was estab- 
